middle.news
Osteopore Gains Strategic Hainan Approval for Orthopaedic Devices with First Surgery Set
8:59am on Tuesday 26th of May, 2026 AEST
•
Healthcare
Read Story
Osteopore Gains Strategic Hainan Approval for Orthopaedic Devices with First Surgery Set
8:59am on Tuesday 26th of May, 2026 AEST
Key Points
Hainan FDA approval enables early commercial use in China’s Boao Lecheng zone
Shanghai Ruijin Hospital is a top-tier 3A-ranked national institution
China orthopaedic devices market projected to grow to USD 4.5 billion by 2035
First patient surgery scheduled for June 2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Osteopore (ASX:OSX)
OPEN ARTICLE